[Viva] Long-term use of HIV drugs is safe, does not raise risk of death, study shows, 13 December 2011
James and Ally Keating
keatingfamilycircus at telus.net
Thu Dec 15 19:14:58 PST 2011
Must admit...for as much as I truely hate the meds...the article does make me feel a bit warmer towards them. I still don't like them but....I take em. 8~) Thanks for the post, Ally
----- Original Message -----
From: shelly tognazzini
To: viva at lists.resist.ca
Sent: Thursday, December 15, 2011 2:25 PM
Subject: Re: [Viva] Long-term use of HIV drugs is safe, does not raise risk of death, study shows, 13 December 2011
Great study. Agreed. Also some great articles. Thanks Kath.
On Dec 14, 2011 11:05 PM, "Kath Webster" <kathwebster at shaw.ca> wrote:
Gotta love the results of this study! Here’s to good quality, healthy long lives for us all ..
From: aidsmapnews at nam.org.uk [mailto:aidsmapnews at nam.org.uk]
Sent: December-13-11 9:12 AM
To: kathwebster at shaw.ca
Subject: aidsmap news: Long-term use of HIV drugs is safe, does not raise risk of death, study shows, 13 December 2011
§ Recent news headlines
§ About NAM
Recent news headlines
Long-term use of HIV drugs is safe, does not raise risk of death, study shows
A large international study has provided persuasive evidence of the long-term safety of antiretroviral therapy. Writing in the online edition of AIDS, investigators from the EuroSIDA study report that prolonged use of antiretroviral therapy did not increase the risk of death from non-AIDS-related illnesses.
Read more >>
Co-infection with hepatitis B worsens HIV-related outcomes
Co-infection with hepatitis B virus increases the risk of AIDS or death for patients newly diagnosed with HIV, investigators from the US military report in the online edition of the Journal of Infectious Diseases.
Read more >>
Hepatitis B genotype B associated with poorer liver-related outcomes in Taiwanese patients co-infected with HIV and hepatitis B
Liver-related outcomes are poorer in HIV-positive patients who are co-infected with hepatitis B virus genotype B compared to co-infected patients with hepatitis B genotype C, Taiwanese investigators report in the online edition of Clinical Infectious Diseases.
Read more >>
Earlier deaths in people with HIV due to drugs, alcohol, co-infections, poorly controlled HIV – not rapid ageing
Patients taking antiretroviral therapy have the same mortality risk as individuals in the general population, according to Danish research published in the open-access journal PLoS One. However, this was only the case when the patients responded to treatment and did not have other factors that increased the risk of serious illness and death, such as co-infections or co-morbidities, or drug and alcohol misuse.
Read more >>
Treatment switches after CD4 count decline reduce risk of death by 75% in Zambia, Malawi
Mortality was reduced by about 75% among adults experiencing immunological failure according to the World Health Organization criteria who switched to a second-line regimen compared to those who remained on a failing regimen in two public sector ART programmes without access to routine viral load monitoring in Zambia and Malawi, researchers report in the advance online edition of AIDS.
Read more >>
Hepatitis C doesn’t affect cognitive function of women, but some evidence HIV does
Infection with hepatitis C does not affect the cognitive performance of women with or at risk of HIV, according to data from the Women’s Interagency HIV Study published in the online edition of the Journal of Acquired Immune Deficiency Syndromes.
Read more >>
Mild kidney problems in patients with HIV can identify patients with hardening of the arteries
Emergent kidney dysfunction is associated with an increased risk of hardening of the arteries in patients with HIV, Spanish researchers show in the online edition of the Journal of Acquired Immune Deficiency Syndromes.
Read more >>
Cardiovascular risks reduced for patients with HIV by therapy with metformin and changes to diet and exercise
Treatment with the anti-diabetes drug metformin helps prevent the progression of sub-clinical cardiovascular disease in patients with HIV, according to the results of a randomised, placebo-controlled study published in the online edition of AIDS.
Read more >>
High rate of new diagnoses when gay men phoned and asked to come back for sexual health check-up
It’s feasible for sexual health clinics to take steps to invite ‘high-risk’ patients to come back for re-screening, and doing so leads to a high number of new diagnoses being made, London clinicians report in the December issue of Sexually Transmitted Infections.
Read more >>
Obama: US aims to provide HIV drugs for extra 2 million by end of 2013
The United States will aim to provide antiretroviral treatment for 6 million people around the world by 2013, President Barack Obama announced today, increasing the original US target by 2 million.
Read more >>
UK considering lifting restrictions on health workers with HIV – as long as viral load is undetectable
The Department of Health has opened a consultation on possible changes to its policy on the employment of people with HIV. The current ban on people with HIV performing specific procedures in surgery, dentistry and gynaecology may be lifted, so that staff who are taking antiretroviral therapy and have a viral load below 200 copies/ml could work in the NHS.
Read more >>
Undiagnosed infections and poor retention in care mean that few US patients fully benefit from HIV treatment
Only a small minority of HIV-positive patients in the United States are gaining the full benefit of antiretroviral therapy, a study published in the November 29th edition of Morbidity and Mortality Weekly Report shows. Investigators calculated that only a half of all patients are retained in care and that only 28% of people infected with HIV in the US have an undetectable viral load.
Read more >>
New vaccine against pneumococcal disease approved for UK
A new vaccine that may be more suitable for preventing pneumococcal disease in people living with HIV has been approved in the United Kingdom.
Read more >>
LGV cases almost triple in one year; UK public health officials warn against serosorting
The number of gay men infected with the sexually transmitted infection lymphogranuloma venereum (LGV) has almost tripled in one year, and the UK now has the world’s worst epidemic of LGV, the Health Protection Agency reported today. At the same time, the agency is tracking an outbreak in gay men of shigellosis, a bacterial infection that is transmitted through contact with tiny amounts of human faeces.
Read more >>
3000 UK gay men diagnosed with HIV in 2010 – the highest number ever reported
Against a background of fewer diagnoses among heterosexuals infected abroad, the number of gay men diagnosed with HIV in the UK continues to rise, the Health Protection Agency announced today. Moreover, one quarter of them had recently acquired their infection, suggesting a high level of risk taking in this group.
Read more >>
Raltegravir kinder to bones and body fat than boosted protease inhibitors in Spanish trial
Raltegravir (Isentress)-based treatment appears to have a more favourable impact on fat accumulation and bone metabolism compared to therapy based on a ritonavir-boosted protease inhibitor, according to Spanish research published in the online edition of AIDS.
Read more >>
Patients on HIV therapy have an increased risk of stress and fragility fractures; no link to specific drug
Patients taking antiretroviral therapy have an increased risk of fractures typically associated with low bone mineral density, Danish investigators report in the online edition of AIDS.
Read more >>
About NAM
Talking points
At the British HIV Association (BHIVA) conference last month, we launched Talking points, a tool designed to help people with HIV talk to their doctors about HIV treatment.
The first step is to complete a short questionnaire (you won't be asked for your name) and Talking points will then produce a checklist, based on your answers, of points you may want to talk to your doctor about.
The checklist can be saved as a PDF, printed or emailed, so you can use it to prepare for your next doctor's appointment, or even take it with you to show to your doctor.
Visit aidsmap.com/talking-points
A senior moment
Read John's story, A senior moment: seroconversion late in life on our website.
You can read lots of personal stories from people living with HIV on our website, in the In your own words section. If you have a story to share, please get in touch either by emailing info at nam.org.uk or by using the form on the website. Visit aidsmap.com/inyourownwords
Standards for support
Support, counselling and skilled psychological help should be part of the services available to people with HIV.
A new standards document from the British Psychological Society (BPS), the British HIV Association (BHIVA) and the Medical Foundation for AIDS and Sexual Health (MedFASH) sets out what services should be provided.
Read our recent article on the draft document Help when you're troubled.
Putting faces to names
Ever wondered what the staff at NAM look like? Well, wonder no more – we've just added photographs to our staff team webpage.
We'd like to say a big thank you to our photographer, the lovely Lee Tucker (pictured above with his assistant Anna), a volunteer member of the ZoomIn Photography team (our next-door neighbours here in Lincoln House) who very kindly agreed to come in and give up his time to take photographs of the team.
Come and have a look!
HIV vaccine trials in the UK
The UK's Medical Research Council is currently promoting their website www.helpmakehistory.mrc.ac.uk, which aims to inform and encourage people to register their interest in taking part in clinical trials for HIV vaccines.
There are several trials planned for next year and building up a network of volunteers will help the trial recruitment be more efficient. They need HIV-negative people who are based in the UK to enrol.
Find out more and register online at www.helpmakehistory.mrc.ac.uk.
Very easy fundraising!
Don’t forget! You can raise money for NAM while doing your Christmas shopping – at no extra cost to you!
We are registered on the Easy Fundraising website, which means that when you shop on many popular websites (including Amazon, eBay, iTunes, Tesco and lastminute) the retailer will donate a percentage of your purchase to NAM.
All you have to do is visit the Easy Fundraising website, click on 'find a cause', type in 'NAM' and register your details. Once you've done that you can click through to your favourite websites and start shopping.
Find out more in our blog, or go to www.easyfundraising.org.uk
Download (free!) HIV service listings for world regions
There's a new way to access our unique global HIV services information.
HIV & AIDS services worldwide was published (in print) in its 13th edition earlier this year and can be bought for £24.95.
The information from this publication and the additional information contained in HIV services in the UK can be accessed through our online tool, the e-atlas.
We've now also made PDFs of the world region sections available to download, free of charge. Find out more on our website.
NAM Publications
Registered office: Lincoln House, 1 Brixton Road, London SW9 6DE
Company limited by guarantee. Registered in England & Wales, number: 2707596
Registered charity, number: 1011220
tel: +44 (0)20 7840 0050 | fax: +44 (0)20 7735 5351 | email: info at nam.org.uk | web: www.aidsmap.com
To unsubscribe from this email, please visit www.aidsmap.com/page/1492854/
----------------------------------------------------------------------------
No virus found in this message.
Checked by AVG - www.avg.com
Version: 2012.0.1873 / Virus Database: 2102/4677 - Release Date: 12/12/11
_______________________________________________
Viva mailing list
Viva at lists.resist.ca
https://lists.resist.ca/cgi-bin/mailman/listinfo/viva
------------------------------------------------------------------------------
_______________________________________________
Viva mailing list
Viva at lists.resist.ca
https://lists.resist.ca/cgi-bin/mailman/listinfo/viva
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.resist.ca/pipermail/viva/attachments/20111215/66c31782/attachment-0001.html>
More information about the Viva
mailing list